Physician profile

Paul David Weiner

Foot & Ankle Surgery · Vallejo, CA

NPI 1730167370

$5,695.18

in general payments reported to CMS, 2019-2025

39 companies · $1,163 in 2025

The $1,163 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).

See the full distribution for Foot & Ankle Surgery

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$3,085.45
Education$109.00
Debt Forgiveness$25.70

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Smith+Nephew, INC. $1,355.96 2019-2025 Oasis Micro, Grafix Pl, Stravix Pl
Stryker Corporation $438.18 2020-2025 Augment Injectable, Infinity, 7 X 23mm Citrelock Implant
Mimedx Group, INC. $384.76 2024-2025
Abbott Laboratories $361.63 2022-2025 Proclaim
Amgen INC. $350.28 2024-2025 Krystexxa
Orthofix Medical, INC. $236.17 2021-2024 Physio-Stim, Accelstim
Bioventus LLC $205.46 2021-2024 Exogen Ultrasound Bone Healing System
Biocomposites INC $182.74 2023-2024 Stimulan
Depuy Synthes Sales INC. $182.07 2020-2025 Na, Motoband, Minibunion
Medtronic Vascular, INC. $179.10 2019
Tactile Systems Technology INC $162.73 2024 Entre Plus, Flexitouch Plus
Curonix LLC $149.98 2025 Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A
Djo, LLC $134.70 2023-2024 Dr Comfort
Nevro Corp. $130.00 2023 Senza
Medtronic, INC. $124.16 2024-2025 Intellis Adaptivestim
Show all 39 companies
CompanyGeneral paymentsYearsTop products
Sanara Medtech INC. $120.15 2022-2023 Celleraterx
Zimmer Biomet Holdings, INC. $109.30 2019
Integra Lifesciences Corporation $98.73 2020-2023 Integra, Primatrix, Integra Dermal Regeneration Template
Paragon 28, INC. $90.32 2019-2024 Paratrooper, Grappler, Portfolio
Organogenesis INC. $85.61 2019-2022
Ortho Dermatologics, A Division of Bausch Health US, LLC $75.95 2021
Wright Medical Technology, INC. $73.27 2019-2020
Treace Medical Concepts, INC. $67.84 2023-2025
Access Pro Medical, LLC $55.93 2025 Matriderm
Paratek Pharmaceuticals, INC. $40.26 2025 Nuzyra
Pfizer INC. $32.77 2019
Derma Sciences, INC. $32.00 2019
Urgo Medical North America, LLC $30.39 2025 Urgok2
Next Science LLC $28.71 2022
Vertex Pharmaceuticals Incorporated $26.42 2025
Averitas Pharma INC. $23.79 2023 Qutenza
Osiris Therapeutics INC. $21.00 2019
Evolution Surgical, INC $19.16 2025
Convatec INC. $16.77 2022
Merck Sharp & Dohme LLC $15.23 2019
Advanced Oxygen Therapy INC. $14.87 2023 Topical Oxygen Chamber For Extremities
Nabriva Therapeutics, Plc $13.33 2022
Rikco International, LLC $12.84 2019
Medela LLC $12.62 2021

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Paul David Weiner

$5,695.18

in general payments reported 2019-2025

Years
2019-2025
Top company
Smith+Nephew, INC.
Context
The $1,163 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).

https://glasscript.com/doctor/33742/paul-david-weiner

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.